Published in Virchows Arch B Cell Pathol Incl Mol Pathol on January 01, 1983
Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol (1984) 2.39
Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg (1988) 1.19
Surgical management and prognostic factors in patients with subungual melanoma. Ann Surg (1994) 1.09
DNA content and MHC class II antigen expression in malignant melanoma: clinical course. J Clin Pathol (1988) 0.86
DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation. Br J Ophthalmol (1995) 0.85
DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma. Br J Cancer (1991) 0.84
Human endogenous retroviral K element encodes fusogenic activity in melanoma cells. J Carcinog (2013) 0.84
Flow cytometric DNA analysis of lesions from 18 children with langerhans cell histiocytosis (histiocytosis x). Am J Pathol (1990) 0.82
Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma. Br J Cancer (1992) 0.81
Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former. Arch Dermatol Res (1993) 0.80
DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas. Br J Cancer (1995) 0.80
Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method. Arch Dermatol Res (1995) 0.75
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry (1983) 6.38
Duodenal adenomatosis in familial adenomatous polyposis. Gut (2004) 2.38
Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry (1983) 2.32
Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther (2012) 2.20
Dysplastic naevus: histological criteria and their inter-observer reproducibility. Histopathology (1994) 2.09
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res (1993) 1.86
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol (1999) 1.86
Risk of recurrence 5 years or more after primary Lichtenstein mesh and sutured inguinal hernia repair. Br J Surg (2007) 1.82
Factor VII related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch A Pathol Anat Histol (1981) 1.78
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer (2005) 1.68
A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry (1990) 1.68
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst (1999) 1.64
Mental aspects of temporal lobe epilepsy. Follow-up of 74 patients after resection of a temporal lobe. J Neurol Neurosurg Psychiatry (1979) 1.63
Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg (2003) 1.61
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol (2000) 1.58
Serum YKL-40 and colorectal cancer. Br J Cancer (1999) 1.57
Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry (1983) 1.56
The intra-lesional variation of type, level of invasion, and tumour thickness of primary cutaneous malignant melanoma. Acta Pathol Microbiol Scand A (1980) 1.55
Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Eur J Surg Oncol (2000) 1.48
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48
Lactational competence and involution of the mouse mammary gland require plasminogen. Development (2000) 1.48
Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg (2000) 1.47
Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand (1999) 1.47
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer (2002) 1.47
The bone-marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Danish CLL Study Group. Eur J Haematol (1996) 1.45
Ranitidine as adjuvant treatment in colorectal cancer. Br J Surg (2002) 1.41
Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood (1998) 1.41
[Dietary treatment of diabetes mellitus. Background and rationale for recommendations in the 1990's]. Ugeskr Laeger (1992) 1.38
Long-term storage of samples for flow cytometric DNA analysis. Cytometry (1983) 1.36
Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res (2000) 1.31
A precise and efficient stereological method for determining murine lung metastasis volumes. Am J Pathol (2001) 1.28
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res (2000) 1.27
Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood (1998) 1.27
The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer (1988) 1.25
Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr Relat Cancer (2005) 1.24
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer (1999) 1.24
Sunscreens for delay of ultraviolet induction of skin tumors. J Am Acad Dermatol (1982) 1.24
Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci (2006) 1.22
Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer. Br J Surg (2008) 1.18
Leiomyosarcoma of the urinary bladder after cyclophosphamide. J Clin Oncol (1995) 1.18
Detergent and proteolytic enzyme-based techniques for nuclear isolation and DNA content analysis. Methods Cell Biol (1994) 1.17
DNA-binding proteins in Yoshida ascites tumor fluid. Biochim Biophys Acta (1976) 1.17
Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. J Invest Dermatol (2000) 1.12
An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours. J Clin Pathol (1985) 1.12
Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat (2000) 1.12
Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses. Am J Clin Pathol (1985) 1.11
Flow cytometric discrimination of mitotic cells: resolution of M, as well as G1, S, and G2 phase nuclei with mithramycin, propidium iodide, and ethidium bromide after fixation with formaldehyde. Cytometry (1986) 1.09
Psychoses in drug-resistant temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1979) 1.08
Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun (2007) 1.08
The BPRS: psychometric developments. Psychopharmacol Bull (1988) 1.08
Histiocytic sarcomas and monoblastic leukemias. A clinical, histologic, and immunophenotypical study. Am J Clin Pathol (1994) 1.07
Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest (2002) 1.07
Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. Cancer Res (1980) 1.05
Changing bone marrow micro-environment during development of acute myeloid leukaemia in rats. Br J Haematol (1998) 1.05
Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats. Cell Prolif (2000) 1.04
T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol (1993) 1.03
Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch A Pathol Anat Histol (1981) 1.03
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis. Br J Cancer (2006) 1.02
Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer (1993) 1.01
Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer. BMJ (1998) 1.01
Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases. Cancer (1986) 1.01
Organisation of the Danish adjuvant trials in breast cancer. Dan Med Bull (1981) 1.01
Characterization and expression of the human T cell receptor-T3 complex by monoclonal antibody F101.01. Scand J Immunol (1988) 1.00
A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kinet (1982) 1.00
Effect of chronic and experimental jaw muscle pain on pain-pressure thresholds and stimulus-response curves. J Orofac Pain (1995) 1.00
Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med (1988) 0.99
Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol (1979) 0.99
Soluble urokinase plasminogen activator receptor measurements: influence of sample handling. Int J Biol Markers (2002) 0.99
Learning effect of isokinetic measurements in healthy subjects, and reliability and comparability of Biodex and Lido dynamometers. Clin Physiol Funct Imaging (2005) 0.99
Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol (2006) 0.99
Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients. Melanoma Res (1999) 0.98
In situ immunological characterization of Langerhans cells with monoclonal antibodies: comparison with other dendritic cells in skin and lymph nodes. Virchows Arch A Pathol Anat Histopathol (1984) 0.98
Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. Colorectal Dis (2011) 0.97
A method to study cell proliferation kinetics in human gastric mucosa. Gut (1975) 0.97
Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. Scand J Urol Nephrol Suppl (1994) 0.97
DNA flow cytometry on human epidermis: I. methodological studies on normal skin. J Invest Dermatol (1980) 0.97
Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures. Blood (2000) 0.94
Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scand J Gastroenterol (2004) 0.94
Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res (1998) 0.94
Relationship between gastric acid secretion, histopathology, and cell proliferation kinetics in human gastric mucosa. Gastroenterology (1977) 0.93
Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis (2012) 0.93
Single cell DNA measurements in benign cutaneous lymphoid infiltrates and in positive patch tests. Br J Dermatol (1985) 0.93
Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases. Virchows Arch A Pathol Anat Histopathol (1985) 0.92
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin. Br J Cancer (1997) 0.92
Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood (1991) 0.91
Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg (1995) 0.91
Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer. Scand J Immunol (2011) 0.90
Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. Br J Cancer (1984) 0.90